Suppressors of cytokine signaling in health and disease

被引:84
作者
Tan, JC
Rabkin, R
机构
[1] Vet Affairs Palo Alto Hlth Care Syst, Res Serv, Palo Alto, CA 94304 USA
[2] Stanford Univ, Dept Med, Div Nephrol, Stanford, CA 94305 USA
关键词
signal transducer and activator of transcription; Janus-kinase; cytokines; signal transduction; kidney disease;
D O I
10.1007/s00467-004-1766-8
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Cytokines consist of a large family of secreted proteins, including pro-inflammatory agents, growth hormone and erythropoietin, that utilize the Janus kinase (JAK) signal transducer and activator of transcription (STAT) signal transduction pathway to mediate many of their key physiologic and pathologic actions. These actions include cytokine-mediated inflammation, immunoregulation, hematopoiesis and growth. The JAK-STAT pathway is regulated by several processes, among which negative feedback regulation by the suppressors of cytokine signaling (SOCS), members of a family of eight proteins, is particularly important. Each cytokine induces one or more specific SOCS proteins that in turn down-regulate the signal initiated by the cytokine. Through their impact on the cytokine-activated JAK-STAT pathway, the SOCS proteins are involved in many diseases that come to the attention of the pediatric nephrologist. For example, an increase in the expression of SOCS-2 and -3 may be a cause of growth hormone resistance and thus may contribute to the growth retardation that affects children with chronic renal failure. Because of their obvious biologic importance, the SOCS proteins have been the subject of intense research that includes the development of strategies to utilize these proteins to control cytokine-induced JAK/STAT signal transduction for therapeutic purposes.
引用
收藏
页码:567 / 575
页数:9
相关论文
共 81 条
[51]   SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-γ and IL-4 signaling in vivo [J].
Naka, T ;
Tsutsui, H ;
Fujimoto, M ;
Kawazoe, Y ;
Kohzaki, H ;
Morita, Y ;
Nakagawa, R ;
Narazaki, M ;
Adachi, K ;
Yoshimoto, T ;
Nakanishi, K ;
Kishimoto, T .
IMMUNITY, 2001, 14 (05) :535-545
[52]   Activation of the signal transducer and activator of transcription signaling pathway in renal proximal tubular cells by albumin [J].
Nakajima, H ;
Takenaka, M ;
Kaimori, JY ;
Hamano, T ;
Iwatani, H ;
Sugaya, T ;
Ito, T ;
Hori, M ;
Imai, E .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (02) :276-285
[53]   A new modality for immunosuppression: Targeting the JAK/STAT pathway [J].
O'Shea, JJ ;
Pesu, M ;
Borie, DC ;
Changelian, PS .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (07) :555-564
[54]  
Piwien-Pilipuk G, 2002, J PEDIATR ENDOCR MET, V15, P771
[55]   New concepts: growth hormone, insulin-like growth factor-I and the kidney [J].
Rabkin, R ;
Schaefer, F .
GROWTH HORMONE & IGF RESEARCH, 2004, 14 (04) :270-276
[56]   Differential phosphorylation of Janus kinase 2, Stat5A and Stat5B in response to growth hormone in primary rat adipocytes [J].
Ridderstråle, M ;
Groop, L .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2001, 183 (1-2) :49-54
[57]   Suppression of early T-cell-receptor-triggered cellular activation by the Janus kinase 3 inhibitor WHI-P-154 [J].
Säemann, MD ;
Zeyda, M ;
Diakos, C ;
Szekeres, A ;
Böhmig, GA ;
Kelemen, P ;
Parolini, O ;
Stockinger, H ;
Prieschl, EE ;
Stulnig, TM ;
Baumruker, T ;
Zlabinger, GJ .
TRANSPLANTATION, 2003, 75 (11) :1864-1872
[58]   Constitutive expression of SOCS3 confers resistance to IFN-α in chronic myelogenous leukemia cells [J].
Sakai, I ;
Takeuchi, K ;
Yamauchi, H ;
Narumi, H ;
Fujita, S .
BLOOD, 2002, 100 (08) :2926-2931
[59]   The Janus kinase inhibitor, JAB/SOCS-1, is an interferon-γ inducible gene and determines the sensitivity to interferons [J].
Sakamoto, H ;
Kinjyo, I ;
Yoshimura, A .
LEUKEMIA & LYMPHOMA, 2000, 38 (1-2) :49-+
[60]   Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia [J].
Schaefer, F ;
Chen, Y ;
Tsao, T ;
Nouri, P ;
Rabkin, R .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (03) :467-475